Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Times.
Press releases published on July 9, 2025
Medical Supplierz Expands as Global B2B Marketplace for Medical Equipment Trade
EIN Presswire
·
July 9, 2025
KUWAIT, KUWAIT, July 9, 2025 /EINPresswire.com/ -- Medical Supplierz, a digital B2B platform designed specifically for the medical sector, is gaining rapid traction as a trusted online space for global suppliers and healthcare buyers. With increased …
PULSAR ACQUIRES LETHAL GAMING GEAR TO EXPAND PREMIUM MOUSEPAD PORTFOLIO AND BOLSTER NORTH AMERICAN INFRASTRUCTURE
EIN Presswire
·
July 9, 2025
Strategic acquisition strengthens Pulsar’s U.S. operations, forming Puslar Americas Inc., and brings Lethal’s acclaimed mousepads under the Pulsar brand. SEOUL, SOUTH KOREA, July 9, 2025 /EINPresswire.com/ -- Pulsar Gaming Gears (AplusX Inc.), a leading …
HERE and Genesys Partner to Tackle Distracted Driving and Deliver Next-Generation Navigation Experiences in India
GlobeNewswire
·
July 9, 2025
Strategic collaboration brings dynamic maps, real-time traffic updates and integrated safety features to Indian vehicles Partnership supports India’s automotive shift toward software-defined, connected driving experiences Mumbai, India – HERE Technologies, …
ZenaTech lista para beneficiarse de la histórica inversión de 33 mil millones de dólares en defensa de Estados Unidos para inversiones en drones y sistemas autónomos dentro de la ley ‘One Big Beautiful Bill’
GlobeNewswire
·
July 9, 2025
VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), una empresa de tecnología especializada en drones con IA (Inteligencia Artificial), Dron como un Servicio (DaaS), soluciones …
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock
GlobeNewswire
·
July 9, 2025
WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the pricing of its previously …